CLINICAL_TRIALS
trial_result
· 2024-02-26
Clinical Trial Update: Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI) [Phase 4]
Summary
Phase 4 trial update on prazosin and CSF biomarkers in dementia-related conditions; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: Dementia | Phase 4 | Status: TERMINATED | Results posted: 2024-02-26